Ticker Details
Arcutis Biotherapeutics, Inc.
IPO Date:	January 31, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$3.05B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.58 | 3.32%
Avg Daily Range (30 D):	$0.50 | 2.11%
Avg Daily Range (90 D):	$0.54 | 2.04%

Institutional Daily Volume
Avg Daily Volume:	1.15M
Avg Daily Volume (30 D):	1.02M
Avg Daily Volume (90 D):	1.16M

Trade Size
Avg Trade Size (Sh.):	98
Avg Trade Size (Sh.) (30 D):	62
Avg Trade Size (Sh.) (90 D):	62

Institutional Trades
Total Institutional Trades:	2,344
Avg Institutional Trade:	$2.24M
Avg Institutional Trade (30 D):	$4.32M
Avg Institutional Trade (90 D):	$3.97M
Avg Institutional Trade Volume:	.16M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.92M
Avg Closing Trade (30 D):	$7.01M
Avg Closing Trade (90 D):	$6.63M
Avg Closing Volume:	205.35K

News

Apr 8, 2026 @ 11:30 AM Arcutis Stock Up 65% as Director Sells 10,000 Shar... Source: Jonathan Ponciano

Feb 27, 2026 @ 9:00 PM Arcutis Management to Present at TD Cowen’s... Source: Na

Feb 25, 2026 @ 9:00 PM Arcutis Announces Fourth Quarter and Full Year 202... Source: Na

Feb 6, 2026 @ 10:18 AM This Biopharma Stock Has Surged Nearly 100% and On... Source: Jonathan Ponciano

Feb 5, 2026 @ 9:00 PM Arcutis Biotherapeutics Reports Inducement Grants ... Source: Not Specified

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.13	$.13	$-.13
Diluted EPS	$-.13	$.13	$-.13
Revenue	$376.07M	$129.5M	$376.07M
Gross Profit	$339.38M	$117.82M	$339.38M
Net Income / Loss	$-16.14M	$17.4M	$-16.14M
Operating Income / Loss	$-12.23M	$18.39M	$-12.23M
Cost of Revenue	$36.7M	$11.69M	$36.7M
Net Cash Flow	$-28.91M	$-4.27M	$-28.91M
PE Ratio